Skip to search formSkip to main contentSkip to account menu

Peritoneal Dialysis, Continuous Ambulatory

Known as: Continuous ambulatory peritoneal dialysis, Continuous ambulatory peritoneal dialysis (CAPD), CAPD 
Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity… 
National Institutes of Health

Related topics

Related topics

4 relations

Broader (2)

Dialysis procedurePeritoneal Dialysis
nursing therapystandards characteristics

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
1998
Review
1998
Coping strategies and quality of life among patients on continuous ambulatory peritoneal dialysis (CAPD).
The present study describes CAPD patients' coping strategies and quality of life. A descriptive-comparative design was chosen and… 
Highly Cited
1991
Highly Cited
1991
In vitro testing of a potentially biocompatible continuous ambulatory peritoneal dialysis fluid.
In the present study a newly formulated dialysis solution (HDF) was tested for its effects on phagocyte viability and function as… 
Highly Cited
1991
Highly Cited
1991
An analysis of ten-year trends in infections in adults on continuous ambulatory peritoneal dialysis (CAPD).
Infectious complications are the Achilles heel of CAPD. To determine trends in these events, we analyzed the CAPD related… 
Highly Cited
1989
Highly Cited
1989
The Peak Concentration Hypothesis: A Urea Kinetic Approach to Comparing the Adequacy of Continuous Ambulatory Peritoneal Dialysis (CAPD) and Hemodialysis
The KTIV urea index (K, clearance; T, treatment time; V, volume of urea distribution) has become an established index of… 
Highly Cited
1989
Highly Cited
1989
Comparative Pharmacokinetics of Recombinant Erythropoietin Administered by the Intravenous, Subcutaneous, and Intraperitoneal Routes in Continuous Ambulatory Peritoneal Dialysis (CAPD) Patients
The single dose pharmacokinetics of recombinant human erythropoietin (r-HuEPO) were compared in six continuous ambulatory… 
Highly Cited
1988
Highly Cited
1988
Renal replacement therapy in patients with diabetic nephropathy, 1980-1985. Report from the European Dialysis and Transplant Association Registry.
Diabetic nephropathy, a rarely listed cause of end-stage renal failure (ESRF) among patients starting renal replacement therapy… 
Highly Cited
1987
Highly Cited
1987
Multi-centre study on outcome of treatment in patients on continuous ambulatory peritoneal dialysis and haemodialysis.
In a multi-centre study by seven large renal units in the United Kingdom, the morbidity and mortality of all patients starting… 
Highly Cited
1984
Highly Cited
1984
Surgical aspects of continuous ambulatory peritoneal dialysis — 3 years experience
Since January 1979, 122 patients (mean age 38.5 years, range 5–72 years) with chronic renal failure have been treated with… 
Highly Cited
1983
Highly Cited
1983
Histological renal osteodystrophy, and 25 hydroxycholecalciferol and aluminum levels in patients on continuous ambulatory peritoneal dialysis.
Renal osteodystrophy, which influences the quality of life and contributes to the morbidity of patients with endstage renal… 
Highly Cited
1981
Highly Cited
1981
"Eosinophilic" peritonitis in continuous ambulatory peritoneal dialysis (CAPD).
Three cases of "sterile" peritonitis in CAPD patients are discussed, where the predominant white cell type in the peritoneal… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)